David Kass, M.D., is the Abraham and Virginia Weiss Professor of Cardiology, Professor of Medicine, Biomedical Engineering, Pharmacology and Molecular Sciences at Johns Hopkins University, where he also directs the Institute of CardioScience. Dr. Kass earned his bachelor degree in applied physics and engineering from Harvard College and M.D. from Yale University. He joined the faculty at Johns Hopkins in 1986 and has been there ever since. His work has been recognized by various awards, including the American Heart Association’s Basic Science Award and Inaugural Melvin Marcus Award, Outstanding Investigator Award from the NIH, Peter Harris Distinguished Scholar Award, and Johns Hopkins Clinical Innovator and Mentor Award and Professor’s Award for Distinction in Teaching. He has published over 400 papers garnering over 56,000 citations, and has trained >100 students/fellows in his laboratory, most now in academic research careers. He co- founded Robin Medical, an engineering company with marketed guidance technology for MR scanners, and Cardioxyl, a pharmaceutical company that developed nitroxyl donors for the treatment of heart failure and was sold to Bristol Myers Squibb in 2015 where advanced Phase II trials continue.